Tronox (NYSE: TROX) posts larger 2025 loss and higher net debt leverage
Tronox Holdings plc reported a much weaker 2025 with higher losses, lower profitability, and rising leverage. Full-year net sales were $2,898 million versus $3,074 million in 2024, while net loss attributable to Tronox widened to $470 million from $48 million.
Adjusted net loss was $237 million compared with an adjusted loss of $12 million in 2024. Adjusted EBITDA fell to $336 million from $564 million, and margin compressed to 11.6% of net sales from 18.3%. Results include $232 million of restructuring and other charges tied to the Botlek and Fuzhou plant closures.
Cash from operating activities dropped to $60 million from $300 million, and free cash flow was negative $281 million. Net debt increased to $3,023 million, pushing net debt to trailing-twelve-month adjusted EBITDA to 9.0x from 4.8x, highlighting a more leveraged balance sheet.
Positive
- None.
Negative
- Sharp earnings deterioration: Net loss attributable to Tronox widened to $470 million in 2025 from $48 million, while adjusted net loss rose to $237 million from $12 million, signaling substantially weaker profitability.
- Margin compression and lower EBITDA: Adjusted EBITDA fell to $336 million from $564 million, with adjusted EBITDA margin declining to 11.6% of net sales from 18.3%, indicating significant pressure on operating margins.
- Leverage and balance sheet risk: Net debt increased to $3,023 million from $2,708 million, and net debt to trailing‑twelve‑month adjusted EBITDA nearly doubled to 9.0x from 4.8x, materially elevating financial leverage.
- Weak cash generation and negative free cash flow: Cash provided by operating activities dropped to $60 million from $300 million, and free cash flow was negative $281 million, limiting internal funding capacity.
- Large restructuring charges: Restructuring and other charges associated with the Botlek and Fuzhou plant closures totaled $232 million in 2025, contributing heavily to reported losses.
Insights
2025 shows sharply weaker earnings, negative free cash flow, and significantly higher leverage for Tronox.
Tronox delivered lower profitability in 2025 despite only a modest decline in sales. Net sales slipped to
Bottom-line results deteriorated materially. Net loss attributable to Tronox expanded to
Restructuring and other charges of
The balance sheet became more stretched. Net debt rose to
|
|
|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
Laporte Road, Stallingborough
|
|
|
|
Grimsby, North East Lincolnshire, DN40 2PR, UK
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
|
|
|
|
| Item 2.02. |
Results of Operations and Financial Condition.
|
| Item 9.01. |
Financial Statements and Exhibits.
|
|
Exhibit
No.
|
Description
|
|
|
99.1
|
Earnings Release, dated February 18, 2026.
|
|
|
104
|
Inline XBRL for the cover page of this Current Report on Form 8-K.
|
|
TRONOX HOLDINGS PLC
|
|||
|
Date: February 19 2026
|
By:
|
/s/ Jeffrey N. Neuman
|
|
|
Name:
|
Jeffrey N. Neuman
|
||
|
Title:
|
Senior Vice President, General Counsel and Secretary
|
||

| • |
Revenue of $730 million
|
| • |
Loss from operations of $114 million; Net loss attributable to Tronox of $176 million including $80 million of restructuring and other charges, net of taxes, primarily associated with the closure of the
Company's Botlek and Fuzhou pigment plants; Adjusted net loss of $96 million (non-GAAP)
|
| • |
Adjusted EBITDA of $57 million; Adjusted EBITDA margin of 7.8% (non-GAAP)
|
| • |
GAAP diluted loss per share of $1.11; Adjusted diluted loss per share of $0.60 (non-GAAP)
|
| • |
Revenue of $2,898 million
|
| • |
Loss from operations of $253 million; Net loss attributable to Tronox of $470 million including $233 million of restructuring and other charges, net of taxes, primarily costs associated with the closure of the
Company's Botlek and Fuzhou pigment plants; Adjusted net loss of $237 million (non-GAAP)
|
| • |
Adjusted EBITDA of $336 million; Adjusted EBITDA margin of 11.6% (non-GAAP)
|
| • |
GAAP diluted loss per share of $2.97; Adjusted diluted loss per share of $1.50 (non-GAAP)
|
| • |
Capital expenditures of $341 million
|
| • |
Expect to generate positive free cash flow in 2026, primarily as a result of improving TiO2 pricing and volumes, lower capital expenditures, and targeted actions on working capital
|
| • |
Q1 2026 TiO2 and zircon volumes expected to be relatively in-line with strong Q4 2025 volume levels
|
| • |
TiO2 pricing expected to improve in Q1 2026 and zircon pricing expected to improve in Q2 2026
|
| • |
Q1 2026 Adjusted EBITDA expected to be $55-$65 million
|
|
($M unless otherwise noted)
|
Q4 2025
|
Q4 2024
|
Y-o-Y%∆
|
|
Q3 2025
|
Q-o-Q%∆
|
|
|||||||||||||||
|
Revenue
|
$
|
730
|
$
|
676
|
8
|
%
|
$
|
699
|
4
|
%
|
||||||||||||
|
TiO2
|
$
|
577
|
$
|
533
|
8
|
%
|
$
|
550
|
5
|
%
|
||||||||||||
|
Zircon
|
$
|
78
|
$
|
75
|
4
|
%
|
$
|
59
|
32
|
%
|
||||||||||||
|
Other products
|
$
|
75
|
$
|
68
|
10
|
%
|
$
|
90
|
(17
|
)%
|
||||||||||||
|
(Loss) income from operations
|
$
|
(114
|
)
|
$
|
48
|
n/m
|
|
$
|
(43
|
)
|
(165
|
)%
|
||||||||||
|
Net (Loss)
|
$
|
(177
|
)
|
$
|
(30
|
)
|
n/m
|
|
$
|
(100
|
)
|
n/m
|
|
|||||||||
|
Net (Loss) attributable to Tronox
|
$
|
(176
|
)
|
$
|
(30
|
)
|
n/m
|
|
$
|
(99
|
)
|
n/m
|
|
|||||||||
|
GAAP diluted (loss) per share
|
$
|
(1.11
|
)
|
$
|
(0.19
|
)
|
n/m
|
|
$
|
(0.63
|
)
|
n/m
|
|
|||||||||
|
Adjusted diluted (loss) earnings per share
|
$
|
(0.60
|
)
|
$
|
0.03
|
n/m
|
|
$
|
(0.46
|
)
|
n/m
|
|
||||||||||
|
Adjusted EBITDA
|
$
|
57
|
$
|
129
|
(56
|
)%
|
$
|
74
|
(23
|
)%
|
||||||||||||
|
Adjusted EBITDA Margin %
|
7.8
|
%
|
19.1
|
%
|
(1,130) bps
|
10.6
|
%
|
(280)bps
|
||||||||||||||
|
Free cash flow
|
$
|
53
|
$
|
(35
|
)
|
n/m
|
|
$
|
(137
|
)
|
n/m
|
|
||||||||||
|
Y-o-Y%∆
|
|
Q-o-Q%∆
|
|
|||||||||||||||||||
|
Volume
|
|
Price/Mix
|
FX | Volume |
|
Price/Mix
|
FX
|
|||||||||||||||
|
TiO2
|
13
|
% |
(8
|
)%
|
3
|
%
|
9
|
%
|
(4
|
)%
|
—
|
%
|
||||||||||
|
Zircon
|
27
|
% |
(23
|
)%
|
—
|
%
|
42
|
%
|
(10
|
)%
|
—
|
%
|
||||||||||
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net sales
|
$
|
730
|
$
|
676
|
$
|
2,898
|
$
|
3,074
|
||||||||
|
Cost of goods sold
|
691
|
559
|
2,629
|
2,559
|
||||||||||||
|
Gross profit
|
39
|
117
|
269
|
515
|
||||||||||||
|
Restructuring and other charges
|
79
|
—
|
232
|
—
|
||||||||||||
|
Selling, general and administrative expenses
|
74
|
69
|
290
|
296
|
||||||||||||
|
(Loss) Income from operations
|
(114
|
)
|
48
|
(253
|
)
|
219
|
||||||||||
|
Interest expense
|
(54
|
)
|
(41
|
)
|
(189
|
)
|
(167
|
)
|
||||||||
|
Interest income
|
2
|
1
|
6
|
10
|
||||||||||||
|
Loss on extinguishment of debt
|
—
|
—
|
—
|
(3
|
)
|
|||||||||||
|
Other (expense) income, net
|
(13
|
)
|
7
|
(22
|
)
|
14
|
||||||||||
|
(Loss) income before income taxes
|
(179
|
)
|
15
|
(458
|
)
|
73
|
||||||||||
|
Income tax benefit (provision)
|
2
|
(45
|
)
|
(15
|
)
|
(127
|
)
|
|||||||||
|
Net loss
|
(177
|
)
|
(30
|
)
|
(473
|
)
|
(54
|
)
|
||||||||
|
Net loss attributable to noncontrolling interest
|
(1
|
)
|
—
|
(3
|
)
|
(6
|
)
|
|||||||||
|
Net loss attributable to Tronox Holdings plc
|
$
|
(176
|
)
|
$
|
(30
|
)
|
$
|
(470
|
)
|
$
|
(48
|
)
|
||||
|
Loss per share:
|
||||||||||||||||
|
Basic
|
$
|
(1.11
|
)
|
$
|
(0.19
|
)
|
$
|
(2.97
|
)
|
$
|
(0.31
|
)
|
||||
|
Diluted
|
$
|
(1.11
|
)
|
$
|
(0.19
|
)
|
$
|
(2.97
|
)
|
$
|
(0.31
|
)
|
||||
|
Weighted average shares outstanding, basic (in thousands)
|
158,617
|
158,038
|
158,484
|
157,819
|
||||||||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
158,617
|
158,038
|
158,484
|
157,819
|
||||||||||||
|
Other Operating Data:
|
||||||||||||||||
|
Capital expenditures
|
68
|
117
|
341
|
370
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
82
|
71
|
302
|
285
|
||||||||||||
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net loss attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
(176
|
)
|
$
|
(30
|
)
|
$
|
(470
|
)
|
$
|
(48
|
)
|
||||
|
Restructuring and other charges (a)
|
79
|
—
|
228
|
—
|
||||||||||||
|
Loss on extinguishment of debt (b)
|
—
|
—
|
—
|
3
|
||||||||||||
|
Sale of royalty interest (c)
|
—
|
—
|
—
|
(21
|
)
|
|||||||||||
|
Other (d)
|
1
|
1
|
5
|
5
|
||||||||||||
|
Tax valuation allowance (e)
|
—
|
33
|
—
|
49
|
||||||||||||
|
Adjusted net (loss) income attributable to Tronox Holdings plc (non-U.S. GAAP) (1)(2)
|
$
|
(96
|
)
|
$
|
4
|
$
|
(237
|
)
|
$
|
(12
|
)
|
|||||
|
Diluted net loss per share (U.S. GAAP)
|
$
|
(1.11
|
)
|
$
|
(0.19
|
)
|
$
|
(2.97
|
)
|
$
|
(0.31
|
)
|
||||
|
Restructuring and other charges, per share
|
0.50
|
—
|
1.44
|
—
|
||||||||||||
|
Loss on extinguishment of debt, per share
|
—
|
—
|
—
|
0.02
|
||||||||||||
|
Sale of royalty interest, per share
|
—
|
—
|
—
|
(0.13
|
)
|
|||||||||||
|
Other, per share
|
0.01
|
0.01
|
0.03
|
0.03
|
||||||||||||
|
Tax valuation allowance, per share
|
—
|
0.21
|
—
|
0.31
|
||||||||||||
|
Diluted adjusted net (loss) income per share attributable to Tronox Holdings plc (non-U.S. GAAP) (2)
|
$
|
(0.60
|
)
|
$
|
0.03
|
$
|
(1.50
|
)
|
$
|
(0.08
|
)
|
|||||
|
Weighted average shares outstanding, diluted (in thousands)
|
158,617
|
158,262
|
158,484
|
157,819
|
||||||||||||
|
December 31, 2025
|
December 31, 2024
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
199
|
$
|
151
|
||||
|
Restricted cash
|
12
|
1
|
||||||
|
Accounts receivable (net of allowance of $1 in 2025 and $1 in 2024)
|
289
|
266
|
||||||
|
Inventories, net
|
1,652
|
1,551
|
||||||
|
Prepaid and other assets
|
112
|
184
|
||||||
|
Income taxes receivable
|
1
|
2
|
||||||
|
Total current assets
|
2,265
|
2,155
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
2,007
|
1,927
|
||||||
|
Mineral leaseholds, net
|
608
|
616
|
||||||
|
Intangible assets, net
|
214
|
244
|
||||||
|
Lease right of use assets, net
|
173
|
140
|
||||||
|
Deferred tax assets
|
833
|
830
|
||||||
|
Other long-term assets
|
117
|
126
|
||||||
|
Total assets
|
$
|
6,217
|
$
|
6,038
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
481
|
$
|
499
|
||||
|
Accrued liabilities
|
274
|
247
|
||||||
|
Short-term lease liabilities
|
22
|
24
|
||||||
|
Obligations under inventory financing arrangement
|
50
|
—
|
||||||
|
Short-term debt
|
51
|
65
|
||||||
|
Long-term debt due within one year
|
39
|
35
|
||||||
|
Income taxes payable
|
2
|
4
|
||||||
|
Total current liabilities
|
919
|
874
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
$
|
3,132
|
$
|
2,759
|
||||
|
Pension and postretirement healthcare benefits
|
81
|
85
|
||||||
|
Asset retirement obligations
|
198
|
172
|
||||||
|
Environmental liabilities
|
39
|
40
|
||||||
|
Long-term lease liabilities
|
148
|
107
|
||||||
|
Deferred tax liabilities
|
208
|
174
|
||||||
|
Other long-term liabilities
|
43
|
36
|
||||||
|
Total liabilities
|
4,768
|
4,247
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par
value $0.01 — 158,557,858 shares issued and outstanding at December
31, 2025 and 157,938,056 shares issued and outstanding at December 31, 2024
|
2
|
2
|
||||||
|
Capital in excess of par value
|
2,103
|
2,084
|
||||||
|
Retained Earnings
|
30
|
555
|
||||||
|
Accumulated other comprehensive loss
|
(717
|
)
|
(880
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
1,418
|
1,761
|
||||||
|
Noncontrolling interest
|
31
|
30
|
||||||
|
Total equity
|
1,449
|
1,791
|
||||||
|
Total liabilities and equity
|
$
|
6,217
|
$
|
6,038
|
||||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net loss
|
$
|
(473
|
)
|
$
|
(54
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by operating activities:
|
||||||||
|
Depreciation, depletion and amortization
|
302
|
285
|
||||||
|
Deferred income taxes
|
12
|
110
|
||||||
|
Share-based compensation expense
|
20
|
21
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
10
|
10
|
||||||
|
Loss on extinguishment of debt
|
-
|
1
|
||||||
|
Restructuring and other charges
|
232
|
-
|
||||||
|
Other non-cash affecting net loss
|
59
|
30
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
(Increase) decrease in accounts receivable, net
|
(9
|
)
|
11
|
|||||
|
Increase in inventories, net
|
(26
|
)
|
(115
|
)
|
||||
|
Decrease in prepaid and other assets
|
59
|
40
|
||||||
|
Restructuring payments
|
(76
|
)
|
-
|
|||||
|
Decrease in accounts payable and accrued liabilities
|
(26
|
)
|
(11
|
)
|
||||
|
Net changes in income tax payables and receivables
|
(2
|
)
|
10
|
|||||
|
Changes in other non-current assets and liabilities
|
(22
|
)
|
(38
|
)
|
||||
|
Cash provided by operating activities
|
60
|
300
|
||||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(341
|
)
|
(370
|
)
|
||||
|
Loans
|
15
|
-
|
||||||
|
Proceeds from the sale of assets
|
4
|
27
|
||||||
|
Purchase of investment securities
|
(6
|
)
|
-
|
|||||
|
Cash used in investing activities
|
(328
|
)
|
(343
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of short-term debt
|
(144
|
)
|
(18
|
)
|
||||
|
Repayments of long-term debt
|
(29
|
)
|
(228
|
)
|
||||
|
Proceeds from short-term debt
|
100
|
55
|
||||||
|
Proceeds from inventory financing arrangement
|
50
|
-
|
||||||
|
Proceeds from long-term debt
|
400
|
217
|
||||||
|
Debt issuance costs
|
(7
|
)
|
(16
|
)
|
||||
|
Dividends paid
|
(48
|
)
|
(80
|
)
|
||||
|
Restricted stock and performance-based shares settled in cash for taxes
|
(1
|
)
|
(1
|
)
|
||||
|
Cash provided by (used in) financing activities
|
321
|
(71
|
)
|
|||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
6
|
(7
|
)
|
|||||
|
Net increase (decrease) in cash and cash equivalents and restricted cash
|
59
|
(121
|
)
|
|||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
152
|
273
|
||||||
|
Cash and cash equivalents and restricted cash at end of period
|
$
|
211
|
$
|
152
|
||||
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(177
|
)
|
$
|
(30
|
)
|
$
|
(473
|
)
|
$
|
(54
|
)
|
||||
|
Interest expense
|
54
|
41
|
189
|
167
|
||||||||||||
|
Interest income
|
(2
|
)
|
(1
|
)
|
(6
|
)
|
(10
|
)
|
||||||||
|
Income tax (benefit) provision
|
(2
|
)
|
45
|
15
|
127
|
|||||||||||
|
Depreciation, depletion and amortization expense
|
82
|
71
|
302
|
285
|
||||||||||||
|
EBITDA (non-U.S. GAAP)
|
(45
|
)
|
126
|
27
|
515
|
|||||||||||
|
Share-based compensation (a)
|
6
|
4
|
20
|
21
|
||||||||||||
|
Loss on extinguishment of debt (b)
|
—
|
—
|
—
|
3
|
||||||||||||
|
Foreign currency remeasurement (c)
|
7
|
(11
|
)
|
6
|
(1
|
)
|
||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (d)
|
(11
|
)
|
1
|
9
|
23
|
|||||||||||
|
Accounts receivable securitization program costs (e)
|
3
|
4
|
13
|
15
|
||||||||||||
|
Sale of royalty interest (f)
|
—
|
—
|
—
|
(28
|
)
|
|||||||||||
|
Restructuring and other charges (g)
|
79
|
—
|
232
|
—
|
||||||||||||
|
Other items (h)
|
18
|
5
|
29
|
16
|
||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
57
|
$
|
129
|
$
|
336
|
$
|
564
|
||||||||
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net sales
|
$
|
730
|
$
|
676
|
$
|
2,898
|
$
|
3,074
|
||||||||
|
Net loss (U.S. GAAP)
|
$
|
(177
|
)
|
$
|
(30
|
)
|
$
|
(473
|
)
|
$
|
(54
|
)
|
||||
|
Net loss (U.S. GAAP) as a % of Net sales
|
(24.2
|
)%
|
(4.4
|
)%
|
(16.3
|
)%
|
(1.8
|
)%
|
||||||||
|
Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales
|
7.8
|
%
|
19.1
|
%
|
11.6
|
%
|
18.3
|
%
|
||||||||
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Long-term debt, net
|
$
|
3,132
|
$
|
2,759
|
||||
|
Short-term debt
|
51
|
65
|
||||||
|
Long-term debt due within one year
|
39
|
35
|
||||||
|
(Less) Cash and cash equivalents
|
(199
|
)
|
(151
|
)
|
||||
|
Net debt
|
$
|
3,023
|
$
|
2,708
|
||||
|
Adjusted EBITDA (non-U.S. GAAP) (see above)
|
336
|
564
|
||||||
|
Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above)
|
9.0
|
x
|
4.8
|
x
|
||||
|
Year Ended
December 31, 2025
|
Nine Months Ended
September 30, 2025
|
Three Months Ended
December 31, 2025
|
||||||||||
|
Cash provided by (used in) operating activities
|
$
|
60
|
$
|
(61
|
)
|
$
|
121
|
|||||
|
Capital expenditures
|
(341
|
)
|
(273
|
)
|
(68
|
)
|
||||||
|
Free cash flow (non-U.S. GAAP)
|
$
|
(281
|
)
|
$
|
(334
|
)
|
$
|
53
|
||||